Control of gene conversion and somatic hypermutation by immunoglobulin promoter and enhancer sequences

Yuan Yang Shu, Sebastian D. Fugmann, David G. Schatz*

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

51 Scopus citations

Abstract

It is thought that gene conversion (GCV) and somatic hypermutation (SHM) of immunoglobulin (Ig) genes occur in two steps: the generation of uracils in DNA by activation-induced cytidine deaminase, followed by their subsequent repair by various DNA repair pathways to generate sequence-diversified products. It is not known how either of the two steps is targeted specifically to Ig loci. Because of the tight link between transcription and SHM, we have investigated the role of endogenous Ig light chain (IgL) transcriptional control elements in GCV/SHM in the chicken B cell line DT40. Promoter substitution experiments led to identification of a strong RNA polymerase II promoter incapable of supporting efficient GCV/SHM. This surprising finding indicates that high levels of transcription are not sufficient for robust GCV/SHM in Ig loci. Deletion of the IgL enhancer in a context in which high-level transcription was not compromised showed that the enhancer is not necessary for GCV/SHM. Our results indicate that cis-acting elements are important for Ig gene diversification, and we propose that targeting specificity is achieved through the combined action of several Ig locus elements that include the promoter. JEM

Original languageEnglish
Pages (from-to)2919-2928
Number of pages10
JournalJournal of Experimental Medicine
Volume203
Issue number13
DOIs
StatePublished - 25 12 2006
Externally publishedYes

Fingerprint

Dive into the research topics of 'Control of gene conversion and somatic hypermutation by immunoglobulin promoter and enhancer sequences'. Together they form a unique fingerprint.

Cite this